Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development of a Well-Characterized Cynomolgus Macaque Model of Sudan Virus Disease for Support of Product Development.
Alfson KJ, Goez-Gazi Y, Gazi M, Chou YL, Niemuth NA, Mattix ME, Staples H, Klaffke B, Rodriguez GF, Escareno P, Bartley C, Ticer A, Clemmons EA, Dutton Iii JW, Griffiths A, Meister GT, Sanford DC, Cirimotich CM, Carrion R Jr. Alfson KJ, et al. Among authors: sanford dc. Vaccines (Basel). 2022 Oct 15;10(10):1723. doi: 10.3390/vaccines10101723. Vaccines (Basel). 2022. PMID: 36298588 Free PMC article.
Use of a treadmill, lift, and carry battery as a composite functional performance test: analysis of data from a pragmatic randomized controlled trial in a military population participating in a functional restoration program.
Snow T, Burke L, Sanford DC, Mathew A, Steffen AD, Flynn DM, Doorenbos AZ. Snow T, et al. Among authors: sanford dc. Physiother Theory Pract. 2024 Mar 3;40(3):647-657. doi: 10.1080/09593985.2022.2135149. Epub 2022 Oct 25. Physiother Theory Pract. 2024. PMID: 36282735 Clinical Trial.
Development of a Well-Characterized Cynomolgus Macaque Model of Marburg Virus Disease for Support of Vaccine and Therapy Development.
Alfson KJ, Goez-Gazi Y, Gazi M, Chou YL, Niemuth NA, Mattix ME, Staples HM, Klaffke B, Rodriguez GF, Bartley C, Ticer A, Clemmons EA, Dutton JW 3rd, Griffiths A, Meister GT, Sanford DC, Cirimotich CM, Carrion R Jr. Alfson KJ, et al. Among authors: sanford dc. Vaccines (Basel). 2022 Aug 14;10(8):1314. doi: 10.3390/vaccines10081314. Vaccines (Basel). 2022. PMID: 36016203 Free PMC article.
Dual-Antigen COVID-19 Vaccine Subcutaneous Prime Delivery With Oral Boosts Protects NHP Against SARS-CoV-2 Challenge.
Gabitzsch E, Safrit JT, Verma M, Rice A, Sieling P, Zakin L, Shin A, Morimoto B, Adisetiyo H, Wong R, Bezawada A, Dinkins K, Balint J, Peykov V, Garban H, Liu P, Bacon A, Bone P, Drew J, Sanford DC, Spilman P, Sender L, Rabizadeh S, Niazi K, Soon-Shiong P. Gabitzsch E, et al. Among authors: sanford dc. Front Immunol. 2021 Sep 16;12:729837. doi: 10.3389/fimmu.2021.729837. eCollection 2021. Front Immunol. 2021. PMID: 34603305 Free PMC article.
Comparative immunogenicity and efficacy of thermostable (lyophilized) and liquid formulation of anthrax vaccine candidate AV7909.
Autumn Smiley M, Sanford DC, Triplett CA, Callahan D, Frolov V, Look J, Ruiz C, Reece JJ, Miles A, Ruiz E, Ionin B, Shearer JD, Savransky V. Autumn Smiley M, et al. Among authors: sanford dc. Vaccine. 2019 Oct 8;37(43):6356-6361. doi: 10.1016/j.vaccine.2019.09.015. Epub 2019 Sep 14. Vaccine. 2019. PMID: 31530467 Free PMC article.
Correlation between anthrax lethal toxin neutralizing antibody levels and survival in guinea pigs and nonhuman primates vaccinated with the AV7909 anthrax vaccine candidate.
Savransky V, Shearer JD, Gainey MR, Sanford DC, Sivko GS, Stark GV, Li N, Ionin B, Lacy MJ, Skiadopoulos MH. Savransky V, et al. Among authors: sanford dc. Vaccine. 2017 Sep 5;35(37):4952-4959. doi: 10.1016/j.vaccine.2017.07.076. Epub 2017 Jul 31. Vaccine. 2017. PMID: 28774566 Free PMC article.
18 results